Evidence map›Paper›PMID 40721828›Full record

ArticleBMC pharmacology & toxicology2025

Preclinic evaluation of the safety of potential anticovid-19 phytomedicine: SAYE PLUS impacts on Wistar rat biochemical and histopathological parameters in sub-chronic toxicity study.

Joël Ouédraogo, Sylvain Ilboudo, Geoffroy Gueswindé Ouédraogo, Gaétan Donzèo Somda, Barthélemy Bonogo, Virginie Dakuyo, Salfo Ouédraogo, Raïnatou Boly, Mathieu Nitiéma, Dofini Réné Magnini and 2 more

Abstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Assessing the Safety of Carbon Dioxide Extracts ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joël OuédraogoDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Sylvain IlboudoDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso. sylvain.ilboudo@gmail.com.
Geoffroy Gueswindé OuédraogoDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Gaétan Donzèo SomdaDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Barthélemy BonogoDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Virginie DakuyoLaboratoires PHYTOFLA, Banfora, BP, 293, Burkina Faso.
Salfo OuédraogoDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Raïnatou BolyDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Mathieu NitiémaDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Dofini Réné MagniniDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.
Rasmané SemdéLaboratoire de Développement du Médicament, Université Joseph KI-ZERBO, Ouagadougou, BP, 7021, Burkina Faso.
Sylvin OuédraogoDépartement de Médecine et Pharmacopée Traditionnelles et Pharmacie, Institut de Recherche en Sciences de la Santé, Ouagadougou, BP, 7047, Burkina Faso.

Funding

Burkina Faso's National Research and Innovation Fund for Development (FONRID) n° AAP_Rapide Covid19_mala infect_1-04 FONRID
6 · The paper itself

Abstract

Although considered safe and widely used, some natural remedies are responsible for health ailments to their users that deserve to be investigated. SAYE PLUS is one of the most widely used traditional recipes as antimalaria for decades and recently against Covid-19 in Burkina Faso and beyond, and is commonly regarded as safe to use. In the present study, sub-chronic toxicity tests were performed orally in Wistar rats at daily doses of 250, 500, and 1000 mg/kg for 90 days, following the guidelines of the Organization for Economic Cooperation and Development (OECD). The results revealed neither symptoms of toxicity nor mortality. Depending on the dose, time frame, or animal sex, compared with the control, SAYE PLUS powder caused a statistically significant reduction in the water and food consumption of the treated rats. Significantly increases in serum creatinine, total protein, hydrogen phosphate ion (PO

Indexed as

COVID-19 Drug TreatmentPlant ExtractsAnimalsFemaleKidneyLiverMaleRatsRats, WistarToxicity Tests, SubchronicPlant ExtractsBiochemical parametersBurkinaFasoMalariaPhytomedicineSAYE PLUSSub-chronic toxicity

Identifiers

PMID40721828
PMCPMC12306133

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.